New aids for the non‐invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell‐free fetal DNA in maternal plasma

Objectives To improve the prenatal diagnosis of achondroplasia by constructing charts of fetal size, defining frequency of sonographic features and exploring the role of non‐invasive molecular diagnosis based on cell‐free fetal deoxyribonucleic acid (DNA) in maternal plasma. Methods Data on fetuses...

Full description

Saved in:

Bibliographic Details
Published in:	Ultrasound in obstetrics & gynecology 2011-03, Vol.37 (3), p.283-289
Main Authors:	Chitty, L. S., Griffin, D. R., Meaney, C., Barrett, A., Khalil, A., Pajkrt, E., Cole, T. J.
Format:	Article
Language:	eng
Subjects:	Achondroplasia Achondroplasia - diagnosis Achondroplasia - diagnostic imaging Achondroplasia - genetics Anthropometry - methods Biological and medical sciences cell‐free fetal DNA Chest Data processing Diseases of the osteoarticular system DNA DNA - blood DNA - genetics Female Femur Fetal Diseases - diagnosis Fetal Diseases - diagnostic imaging Fetal Diseases - genetics fetal size charts fetal ultrasound Fetuses Finger Gestation Gynecology Gynecology. Andrology. Obstetrics Human viral diseases Humans Infectious diseases Malformations and congenital and or hereditary diseases involving bones. Joint deformations Maternal-Fetal Exchange Medical sciences Mutation Mutation - genetics non‐invasive prenatal diagnosis Obstetrics Polymorphism, Single Nucleotide Pregnancy Prenatal diagnosis Prenatal Diagnosis - methods Receptor, Fibroblast Growth Factor, Type 3 - blood Reviews Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization - methods Ultrasonography Ultrasound Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online Access:	Request full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Objectives To improve the prenatal diagnosis of achondroplasia by constructing charts of fetal size, defining frequency of sonographic features and exploring the role of non‐invasive molecular diagnosis based on cell‐free fetal deoxyribonucleic acid (DNA) in maternal plasma. Methods Data on fetuses with a confirmed diagnosis of achondroplasia were obtained from our databases, records reviewed, sonographic features and measurements determined and charts of fetal size constructed using the LMS (lambda‐mu‐sigma) method and compared with charts used in normal pregnancies. Cases referred to our regional genetics laboratory for molecular diagnosis using cell‐free fetal DNA were identified and results reviewed. Results Twenty‐six cases were scanned in our unit. Fetal size charts showed that femur length was usually on or below the 3rd centile by 25 weeks' gestation, and always below the 3rd by 30 weeks. Head circumference was above the 50th centile, increasing to above the 95th when compared with normal for the majority of fetuses. The abdominal circumference was also increased but to a lesser extent. Commonly reported sonographic features were bowing of the femora, frontal bossing, short fingers, a small chest and polyhydramnios. Analysis of cell‐free fetal DNA in six pregnancies confirmed the presence of the c.1138G > A mutation in the FGRF3 gene in four cases with achondroplasia, but not the two subsequently found to be growth restricted. Conclusions These data should improve the accuracy of diagnosis of achondroplasia based on sonographic findings, and have implications for targeted molecular confirmation that can reliably and safely be carried out using cell‐free fetal DNA. Copyright © 2011 ISUOG. Published by John Wiley & Sons, Ltd.
ISSN:	0960-7692 1469-0705 1469-0705